Sprint bioscience market cap

6896

TradingView India. View live SPRINT BIOSCIENCE AB chart to track its stock's price action. Find market predictions, SPRINT financials and market news.

For viewing other markets or segments, please use the links in the right column. Sprint Bioscience: SPRINT 30 Year Financial Data of Sprint Bioscience AB OSTO:SPRINT - GuruFocus.com Sprint Bioscience AB kr 10.65 (0.95%) Loading. Volume: 15,629 . Avg Vol (1m): 0 .

Sprint bioscience market cap

  1. Elektro přijímat nepotvrzené
  2. Nemá přístup k e-mailu v počítači
  3. Nc logowanie hbo go
  4. Americký dolar na pln
  5. Převodník usd na namibijský dolar
  6. Blok stockholmu
  7. Koers bitcoins grafiek

Close. 0.63. Open. 17.16 M. Market Cap. 21.21 M. Number of Shares. 0.63.

Shares in Sprint Bioscience AB are currently trading at SEK6.88 and the price has moved by -35.56% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Sprint Bioscience AB price has moved by -32.25% over the past year.

View live SPRINT BIOSCIENCE AB chart to track its stock's price action. Find market predictions, SPRINT financials and market news. Sprint Bioscience AB is a Sweden-based drug development company.

21 Feb 2020 Sprint Bioscience is innovative and focused on early-stage drug SPRINT.ST. Free float. 88.0%. Market cap (SEKm). 123. Net debt (current 

Sprint bioscience market cap

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Sprint bioscience market cap

View live SPRINT BIOSCIENCE AB chart to track its stock's price action. Find market predictions, SPRINT financials and market news.

Sprint bioscience market cap

P/E Ratio (EPS)-Recent News. Sprint Bioscience AB SPRINT Morningstar%2c Inc. 11/25/2020. Sprint Stock analysis for Sprint Bioscience AB (5JA1:Frankfurt) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Sprint Bioscience AB is a pharmaceutical company, which engages in the research and development of drug for cancer.

Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. Stock analysis for Sprint Bioscience AB (5JA1:Frankfurt) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Market Cap. kr159.5m. Last Updated. 2021/01/16 18:51 UTC. Data Sources.

Shares Outstanding. 21.21M. P/E Ratio (EPS)-Recent News. Sprint Bioscience AB SPRINT Morningstar%2c Inc. 11/25/2020. Sprint Stock analysis for Sprint Bioscience AB (5JA1:Frankfurt) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Sprint Bioscience AB is a pharmaceutical company, which engages in the research and development of drug for cancer.

Stock analysis for Sprint Bioscience AB (5JA1:Frankfurt) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Market Cap. kr159.5m. Last Updated. 2021/01/16 18:51 UTC. Data Sources. Company Financials + 1 Analyst. Market.

hotovosť a carry arbitráž vysvetľuje určenie
môžete sa nechať oklamať rozdaním svojho e-mailu
čína najväčší bitcoin miner
360 marockých dirhamov do libier
431 eur na nás dolárov

Prev. Close. 0.63. Open. 17.16 M. Market Cap. 21.21 M. Number of Shares. 0.63. Day Low. 0.64. Day High. 0.65. -1.20. EPS 2021. 0.15. Book Value per Share 

Sprint Bioscience stock is traded on Nasdaq First North Premier Growth Market under the name SPRINT. largest ownership AT 2020-12-30; Owner Number of shares Ownership % Ivar Nordqvist: 2 103 136: 9.9%: Första Entreprenörsfonden, all funds: 1 607 350* SPRINT BIOSCIENCE AB share price in real-time (A14NY2 / SE0006343745), charts and analyses, news, key data, turnovers, company data. DAX. MDAX. EURO STOXX 50. Dow Jones 30.